肠道和内微生物群:肺癌发展和免疫治疗的关键
Junlan Cai1, Weiguang Zhang2, Shujing Zhu1
1The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
International immunopharmacology
|April 25, 2025
概括
肠道微生物群和肠道内细菌影响肺癌的发展和进展. 了解这些微生物群落可能会导致新的生物标志物和肺癌的治疗策略.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 人们越来越认识到肠道微生物群和内微生物群在癌症发展和进展中的作用.
- 目前对肺癌中这些微生物群落的研究是有限的.
研究的目的:
- 系统地审查关于肠道细菌及其在肺癌形成,进展和转移中的作用的最新发现.
- 分析内微生物群影响肺癌的机制.
- 探索肠道菌群,代谢物和内微生物群在调节肺癌免疫治疗疗效方面的潜力.
主要方法:
- 系统的文献审查.
- 对肠道菌群和肺癌现有研究进行分析.
- 研究内微生物群对肺癌进展的影响.
- 评估微生物在免疫治疗反应中的作用.
主要成果:
- 肠道菌群和内微生物群与肺癌的发展,进展和转移有关.
- 这些微生物群落影响宿主新陈代谢,炎症和免疫反应.
- 特定的细菌物种可能在肺癌中具有保护性或有害作用.
- 微生物群的组成可能会影响肺癌免疫治疗的疗效.
结论:
- 肠道菌群和内微生物群是肺癌检测和预后的潜在生物标志物.
- 准微生物组为新型肺癌疗法提供了一个有希望的途径.
- 进一步的研究至关重要,以阐明微生物群和肺癌之间的复杂相互作用,以优化治疗策略,特别是免疫治疗.
相关概念视频
02:17The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
01:27Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398